Totally Implantable Catheters in Pediatric Hematology-oncology: a Study on Infectious Complications
NCT ID: NCT01304732
Last Updated: 2012-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
158 participants
OBSERVATIONAL
2011-01-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications
NCT05769452
Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients
NCT01343680
Vascular Access in Hematological Patients - PICC Versus CVC
NCT02405728
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia
NCT05793801
Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition
NCT02255318
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grupo de Apoio ao Adolescente e a Crianca com Cancer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Orlei Araujo
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Orlei Araujo, MD
Role: PRINCIPAL_INVESTIGATOR
Grupo de Apoio ao Adolescente e a Crianca com Cancer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grupo de Apoio ao Adolescente e a Criança com Cancer
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0145/11
Identifier Type: OTHER
Identifier Source: secondary_id
UTI/IOP 04/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.